U.S. Markets close in 4 hrs 37 mins

L'Oréal S.A. (OR.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
174.30-6.75 (-3.73%)
As of 5:07PM CEST. Market open.
Full screen
Previous Close181.05
Bid167.00 x 6000
Ask169.85 x 35000
Day's Range174.10 - 178.00
52 Week Range156.50 - 197.15
Avg. Volume560,958
Market Cap97.47B
PE Ratio (TTM)31.69
Earnings DateN/A
Dividend & Yield3.61 (1.74%)
Ex-Dividend Date2017-04-28
1y Target EstN/A
  • Reuters2 days ago

    GlaxoSmithKline's new boss streamlines R&D, axes slew of drugs

    GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals business. Emma Walmsley, who took over in April, said GSK would in future allocate 80 percent of its R&D budget to respiratory and HIV/infectious diseases, along with two other potential areas of oncology and immuno-inflammation.

  • Reuters18 days ago

    Activist Loeb keeps up performance pressure on Nestle -source

    Activist investor Daniel Loeb is keeping up pressure on Nestle by sharing views with the company as part of a regular dialogue, a source familiar with the matter told Reuters. The move came just two days after the billionaire hedge fund manager urged Nestle to more aggressively improve returns as his Third Point fund revealed a $3.5 billion stake that made it Nestle's eighth-largest shareholder. Some analysts now expect Nestle to set, or at least imply, a long-term margin target at its Sept. 26 investor seminar, when new chief executive Mark Schneider will lay out his plans.

  • Moody'slast month

    Nestle Finance International Ltd. -- Moody's affirms Nestle's Aa2 rating; stable outlook

    Rating Action: Moody's affirms Nestlé's Aa2 rating; stable outlook. Global Credit Research- 28 Jun 2017. Milan, June 28, 2017-- Moody's Investors Service has today affirmed the Aa2 issuer rating of the ...